Security Snapshot

Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) Institutional Ownership

CUSIP: 22978P205

13F Institutional Holders and Ownership History from Q1 2026 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

25

Shares (Excl. Options)

1.47MFull value: 1,473,235 · shares · 30 Sep 2026

Price

$25.87

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock, $0.001 par value per share
Symbol
CUE on Nasdaq
All holders as of 30 Sep 2026
Q3 2026
Total 13F shares
1,473,235
Latest holder snapshot 5 signals
Total 13F value
$38,113,706
Portfolio coverage rank
0%
Share change
+785,811
Value change
+$20,329,274
Number of holders
25
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
7,587,247
SEC-reported price per share
$19.57
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share is tracked under CUSIP 22978P205.
  • 25 institutions reported positions in Q3 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 49 to 25 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $52.25MFull value: $52,247,004 · USD · 30 Jun 2026
    to
    $38.11MFull value: $38,113,706 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 25 institutions filings for Q3 2026.

Open SEC evidence

Security key

22978P205

13F reference period

Q3 2026

13F holders

25

13D/G owners

3

CIK / CUSIP context first

Open Q3 2026 holders CUE full holder history Cue Biopharma, Inc. SEC filings Cue Biopharma, Inc. company facts Cue Biopharma, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
CUE
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
STROME MARK E 8.5% $18,057,648 644,916 Mark E. Strome 14 Jul 2026
Lin Shao-Lee 6.2% $14,201,846 467,166 Shao-Lee Lin 03 May 2026
DRIEHAUS CAPITAL MANAGEMENT LLC 7% $10,745,056 292,144 DRIEHAUS CAPITAL MANAGEMENT LLC 30 Jun 2026
As of 30 Sep 2026, 25 institutional investors reported holding
1.47MFull value: 1,473,235 · shares · 30 Sep 2026
shares of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE). This represents 19% of the company’s total
7.59MFull value: 7,587,247 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
19%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Bleichroeder LP 4.8% 366,152 -1.2% 0.93% $9,472,352
VANGUARD CAPITAL MANAGEMENT LLC 4.1% 309,948 +92% 0% $8,018,355
Vivo Capital, LLC 3.7% 280,057 0.8% $7,245,075
MORGAN STANLEY 2.7% 203,957 +30161% 0% $5,276,368
Nantahala Capital Management, LLC 1.3% 96,049 0.14% $2,484,788
GEODE CAPITAL MANAGEMENT, LLC 0.91% 68,911 +44% 0% $1,783,843
VANGUARD FIDUCIARY TRUST CO 0.54% 41,337 +69% 0% $1,069,388
STATE STREET CORP 0.42% 31,976 +126% 0% $827,219
Texas Capital Bank Wealth Management Services Inc 0.36% 27,345 +20% 0.04% $707,415
STIFEL FINANCIAL CORP 0.15% 11,555 +41% 0% $298,927
Robertson Stephens Wealth Management, LLC 0.15% 11,133 0% 0.01% $288,011
RENAISSANCE TECHNOLOGIES LLC 0.14% 10,289 -30% 0% $266,176
ADVISORY RESEARCH INC 0.11% 8,573 0% 0.02% $221,784
Vanguard Global Advisers, LLC 0.04% 2,681 +64% 0% $69,357
Aster Capital Management (DIFC) Ltd 0.03% 2,111 0.02% $54,612
US BANCORP \DE\ 0.01% 400 0% $10,348
SBI Securities Co., Ltd. 0% 300 0% 0% $7,761
Gleason Group, Inc. 0% 200 0% 0% $5,174
NFSG Corp 0% 99 0% 0% $2,561
Tidemark, LLC 0% 50 0% 0% $1,294
Physician Wealth Advisors, Inc. 0% 33 0% 0% $854
MATHER GROUP, LLC. 0% 33 0% 0% $854
GROUP ONE TRADING LLC 0% 30 0% 0% $776
BNP PARIBAS FINANCIAL MARKETS 0% 13 0% $336
IFP Advisors, Inc 0% 3 0% 0% $78

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
3
Headline period
Q3 2026
Rows shown
1-3 of 3
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 1,473,235 $38,113,706 +$20,329,274 $25.87 25
2026 Q2 1,655,525 $52,247,004 +$52,164,365 $31.56 49
2026 Q1 1,700 $391 +$391 $0.23 2
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .